Article Title

Single-dose intraoperative radiotherapy during lumpectomy for breast cancer: An innovative patient-centred treatment

Abstract

In the randomised TARGIT-A trial, risk-adapted targeted intraoperative radiotherapy (TARGIT-IORT) during lumpectomy was non-inferior to whole-breast external beam radiotherapy, for local recurrence. In the long-term, no difference was found in any breast cancer outcome, whereas there were fewer deaths from non-breast-cancer causes. TARGIT-IORT should be included in pre-operative consultations with eligible patients.

Keywords

comment, TARGIT-A trial, radiotherapy, breast cancer, lumpectomy, risk-adapted targeted intraoperative radiotherapy (TARGIT-IORT)

Link to Publisher Version (URL)

10.1038/s41416-020-01233-5

This document is currently not available here.

Find in your library

Share

COinS